Appendix E
Eligibility for MASH (Wegovy) Wegovy is indicated for adults with metabolic dysfunction-associated steatohepatitis (MASH or NASH) with moderate to advanced liver scarring (fibrosis) without liver cirrhosis, when the medication is used along with a reduced-calorie diet and exercise
Compounded Semaglutide From Licensed Pharmacies vs
Pharmacokinetic and Drug Interaction Considerations Data on the pharmacokinetic profiles of both peptides remain extremely limited, with minimal characterization of their absorption, distribution, metabolism, and elimination parameters
Rosenstock, J., Reusch, J., Bush, M., Yang, F., Stewart, M
J., Cherng, W